导致扩张型心肌病的突变ACTC E361G存在于心肌肌原纤维中,它特异性地消除了肌钙蛋白I磷酸化对Ca(2+)调节的调控作用。

The dilated cardiomyopathy-causing mutation ACTC E361G in cardiac muscle myofibrils specifically abolishes modulation of Ca(2+) regulation by phosphorylation of troponin I.

作者信息

Vikhorev Petr G, Song Weihua, Wilkinson Ross, Copeland O'Neal, Messer Andrew E, Ferenczi Michael A, Marston Steven B

机构信息

National Heart and Lung Institute, Imperial College London, London, UK.

Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore.

出版信息

Biophys J. 2014 Nov 18;107(10):2369-80. doi: 10.1016/j.bpj.2014.10.024.

Abstract

Phosphorylation of troponin I by protein kinase A (PKA) reduces Ca(2+) sensitivity and increases the rate of Ca(2+) release from troponin C and the rate of relaxation in cardiac muscle. In vitro experiments indicate that mutations that cause dilated cardiomyopathy (DCM) uncouple this modulation, but this has not been demonstrated in an intact contractile system. Using a Ca(2+)-jump protocol, we measured the effect of the DCM-causing mutation ACTC E361G on the equilibrium and kinetic parameters of Ca(2+) regulation of contractility in single transgenic mouse heart myofibrils. We used propranolol treatment of mice to reduce the level of troponin I and myosin binding protein C (MyBP-C) phosphorylation in their hearts before isolating the myofibrils. In nontransgenic mouse myofibrils, the Ca(2+) sensitivity of force was increased, the fast relaxation phase rate constant, kREL, was reduced, and the length of the slow linear phase, tLIN, was increased when the troponin I phosphorylation level was reduced from 1.02 to 0.3 molPi/TnI (EC50 P/unP = 1.8 ± 0.2, p < 0.001). Native myofibrils from ACTC E361G transgenic mice had a 2.4-fold higher Ca(2+) sensitivity than nontransgenic mouse myofibrils. Strikingly, the Ca(2+) sensitivity and relaxation parameters of ACTC E361G myofibrils did not depend on the troponin I phosphorylation level (EC50 P/unP = 0.88 ± 0.17, p = 0.39). Nevertheless, modulation of the Ca(2+) sensitivity of ACTC E361G myofibrils by sarcomere length or EMD57033 was indistinguishable from that of nontransgenic myofibrils. Overall, EC50 measured in different conditions varied over a 7-fold range. The time course of relaxation, as defined by tLIN and kREL, was correlated with EC50 but varied by just 2.7- and 3.3-fold, respectively. Our results confirm that troponin I phosphorylation specifically alters the Ca(2+) sensitivity of isometric tension and the time course of relaxation in cardiac muscle myofibrils. Moreover, the DCM-causing mutation ACTC E361G blunts this phosphorylation-dependent response without affecting other parameters of contraction, including length-dependent activation and the response to EMD57033.

摘要

蛋白激酶 A(PKA)介导的肌钙蛋白 I 磷酸化可降低心肌中 Ca(2+)敏感性,提高 Ca(2+)从肌钙蛋白 C 释放的速率以及舒张速率。体外实验表明,导致扩张型心肌病(DCM)的突变会使这种调节解偶联,但在完整的收缩系统中尚未得到证实。我们采用 Ca(2+)阶跃方案,测量了导致 DCM 的突变 ACTC E361G 对单个转基因小鼠心脏肌原纤维收缩性 Ca(2+)调节的平衡和动力学参数的影响。在分离肌原纤维之前,我们用普萘洛尔处理小鼠,以降低其心脏中肌钙蛋白 I 和肌球蛋白结合蛋白 C(MyBP-C)的磷酸化水平。在非转基因小鼠肌原纤维中,当肌钙蛋白 I 磷酸化水平从 1.02 降至 0.3 molPi/TnI 时,力的 Ca(2+)敏感性增加,快速舒张相速率常数 kREL 降低,缓慢线性相长度 tLIN 增加(EC50 P/unP = 1.8 ± 0.2,p < 0.001)。ACTC E361G 转基因小鼠的天然肌原纤维的 Ca(2+)敏感性比非转基因小鼠肌原纤维高 2.4 倍。令人惊讶的是,ACTC E361G 肌原纤维的 Ca(2+)敏感性和舒张参数并不依赖于肌钙蛋白 I 磷酸化水平(EC50 P/unP = 0.88 ± 0.17,p = 0.39)。然而,肌节长度或 EMD57033 对 ACTC E361G 肌原纤维 Ca(2+)敏感性的调节与非转基因肌原纤维并无差异。总体而言,在不同条件下测得的 EC50 变化范围达 7 倍。由 tLIN 和 kREL 定义的舒张时间进程与 EC50 相关,但分别仅变化 2.7 倍和 3.3 倍。我们的结果证实,肌钙蛋白 I 磷酸化特异性地改变了心肌肌原纤维等长张力的 Ca(2+)敏感性和舒张时间进程。此外,导致 DCM 的突变 ACTC E361G 削弱了这种磷酸化依赖性反应,而不影响收缩的其他参数,包括长度依赖性激活和对 EMD57033 的反应。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3437/4241448/749874b82605/gr1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索